Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
=28 and 
=50; Spectroscopy of 
ZnShand, C. M.*; Podoly
k, Zs.*; G
rska, M.*; Doornenbal, P.*; Obertelli, A.*; Nowacki, F.*; Otsuka, T.*; Sieja, K.*; Tostevin, J. A.*; Tsunoda, T.*; et al.
Physics Letters B, 773, p.492 - 497, 2017/10
Times Cited Count：25 Percentile：87.36(Astronomy & Astrophysics)Sakanaka, Shogo*; Akemoto, Mitsuo*; Aoto, Tomohiro*; Arakawa, Dai*; Asaoka, Seiji*; Enomoto, Atsushi*; Fukuda, Shigeki*; Furukawa, Kazuro*; Furuya, Takaaki*; Haga, Kaiichi*; et al.
Proceedings of 1st International Particle Accelerator Conference (IPAC '10) (Internet), p.2338 - 2340, 2010/05
Future synchrotron light source using a 5-GeV energy recovery linac (ERL) is under proposal by our Japanese collaboration team, and we are conducting R&D efforts for that. We are developing high-brightness DC photocathode guns, two types of cryomodules for both injector and main superconducting (SC) linacs, and 1.3 GHz high CW-power RF sources. We are also constructing the Compact ERL (cERL) for demonstrating the recirculation of low-emittance, high-current beams using above-mentioned critical technologies.
Sakata, Osami*; Furukawa, Yukito*; Goto, Shunji*; Mochizuki, Tetsuro*; Uruga, Tomoya*; Takeshita, Kunikazu*; Ohashi, Haruhiko*; Ohata, Toru*; Matsushita, Tomohiro*; Takahashi, Sunao*; et al.
Surface Review and Letters, 10(2&3), p.543 - 547, 2003/04
Times Cited Count：141 Percentile：96.38(Chemistry, Physical)The main components of a new beamline for surface and interface crystal structure determination at SPring-8 are briefly described. Stages for the beamline monochromator are modified for making an incident X-ray intensity more stable for surface X-ray experiments. Absolute photon flux densities were measured with an incident photon energy. A new ultrahigh vacuum system is introduced with preliminary X-ray measurements from an ordered oxygen on Pt(111) surface.
Matsumura, Akira*; Yamamoto, Tetsuya*; Shibata, Yasushi*; Nakai, Kei*; Zhang, T.*; Matsushita, Akira*; Takano, Shingo*; Endo, Kiyoshi*; Akutsu, Hiroyoshi*; Yamamoto, Kazuyoshi; et al.
Research and Development in Neutron Capture Therapy, p.1073 - 1078, 2002/09
Since 1998 to 2002, a new clinical trial of an intraoperative boron neutron capture therapy (IOBNCT) at JRR-4 of Japan Atomic Energy Institute (JAERI) using BSH with mixed thermal/epithermal neutron beam has been accomplished. There have been 9 patients included in this study. The median survival time (MST) in GBM was 19.8 months and 16.8 months in AA. IOBNCT with mixed thermal/epithermal neutron beam provide better primary radiation effect than conventional therapy in selected cases. Our phase I/II clinical trial was effective in local tumor control. Further clinical trial with new design should be performed to prove the efficacy of IOBNCT.
Yamamoto, Tetsuya*; Matsumura, Akira*; Yamamoto, Kazuyoshi; Kumada, Hiroaki; Torii, Yoshiya; Endo, Kiyoshi*; Matsushita, Akira*; Shibata, Yasushi*; Nose, Tadao*
Research and Development in Neutron Capture Therapy, p.415 - 418, 2002/09
Dose measurements in a patient's brain undergoing intraoperative BNCT (IOBNCT) were compared with calculations by a JAERI computational dosimetry system (JCDS). The maximum thermal neutron flux on the brain surface from the postirradiation measurement averaged 2.33
0.37(
10
cm
s
) and the vascular boron dose averaged 11.41.2 (9.6-12.7) Gy. Using JCDS, the maximum thermal neutron flux in the irradiated volume averaged 2.210.33(10cms), while the target vascular dose averaged 5.7 Gy and varied from 3.5 to 7.8 Gy. As such, in the dose planning for intra-operative irradiation, practical use of JCDS is recommended for uniform volume-dose control of postsurgical brain in IOBNCT.
Yamamoto, Tetsuya*; Matsumura, Akira*; Yamamoto, Kazuyoshi; Kumada, Hiroaki; Hori, Naohiko; Torii, Yoshiya; Endo, Kiyoshi*; Matsushita, Akira*; Yoshida, Fumiyo*; Shibata, Yasushi*; et al.
Research and Development in Neutron Capture Therapy, p.697 - 700, 2002/09
The RBE of dose components generated in boron neutron capture therapy (BNCT) were separately determined in neutron beams at JRR-4. The cell killing effect of the neutron beam with or without the presence of 10B was highly dependent on the neutron beam used, according to the epithermal and fast neutron content in the beam. RBE (BARBEboron) values of the boron capture reaction for an epithermal (ENB), a mixed thermal-epithermal (TNB-1), and a thermal (TNB-2) neutron beams were 3.990.24, 3.040.19 and 1.430.08, respectively.
Nakai, Kei*; Matsumura, Akira*; Yamamoto, Tetsuya*; Shibata, Yasushi*; Zhang, T.*; Akutsu, Hiroyoshi*; Matsuda, M.*; Matsushita, Akira*; Yasuda, Susumu*; Takano, Shingo*; et al.
Research and Development in Neutron Capture Therapy, p.1135 - 1138, 2002/09
7 patients have been undergoing Intraoperative boron neutron capture therapy (IOBNCT) for malignant glioma at Japan Atomic Energy Institute (JAERI). Post-BNCT MRI studies revealed one local recurrence and two distant recurrences. Distant recurrence is uncommon in the conventional radiation therapy. Symptomatic late radiation necrosis occurred in one case.
Matsushita, Akira*; Yamamoto, Tetsuya*; Matsumura, Akira*; Nose, Tadao*; Yamamoto, Kazuyoshi; Kumada, Hiroaki; Torii, Yoshiya; Kashimura, Takanori*; Otake, Shinichi*
Research and Development in Neutron Capture Therapy, p.141 - 143, 2002/09
A thermal-epithermal mixed beam "Thermal Neutron Beam Mode I" was used in the eleven sessions of boron neutron capture therapy which have been performed at JRR-4 from 1998. We are planning to use an epithermal beam for the treatment of deeper tumors in the next trial of the intraoperative BNCT. In this study, "Epi-12" which was made by putting up a cadmium shutter of "Thermal Neutron Beam Mode I" was investigated for the clinical benefits and safety by epithermal beams. Decrease of fast neutron contamination ratio in Epi-12 mode is the advantage for BNCT, particular in the intraoperative BNCT. Because fast neutron on the brain surface is one of the critical factors in the intraoperative BNCT in which the plain beam directly interacts the normal structures. Furthermore a mixture of mode Epi-12 and Th-12 will provide various dose distribution designs. It may be used as a new method to control the best distribution for individual tumors.
Matsumura, Akira*; Yamamoto, Tetsuya*; Shibata, Yasushi*; Nakai, Kei*; Zhang, T.*; Akutsu, Hiroyoshi*; Matsushita, Akira*; Yasuda, Susumu*; Takano, Shingo*; Nose, Tadao*; et al.
Posuto Shikuensu Jidai Ni Okeru Noshuyo No Kenkyu To Chiryo, p.427 - 435, 2002/07
no abstracts in English
(
=Pt, Pd; 
=P, As, Sb)Iwasaki, T.*; Sekiyama, Akira*; Yamasaki, Atsushi*; Okazaki, Makoto*; Kadono, Koji*; Utsunomiya, Hiroshi*; Imada, Shin*; Saito, Yuji; Muro, Takayuki*; Matsushita, Tomohiro*; et al.
Physical Review B, 65(19), p.195109_1 - 195109_9, 2002/05
Times Cited Count：24 Percentile：71.84(Materials Science, Multidisciplinary)no abstracts in English
Saito, Yuji; Kimura, Hiroaki*; Suzuki, Yoshio*; Nakatani, Takeshi*; Matsushita, Tomohiro*; Muro, Takayuki*; Miyahara, Tsuneaki*; Fujisawa, M.*; Soda, Kazuo*; Ueda, Shigenori*; et al.
Nuclear Instruments and Methods in Physics Research A, 467-468(Part.1), p.553 - 556, 2001/07
Times Cited Count：23 Percentile：82.42(Instruments & Instrumentation)no abstracts in English
Nose, Tadao*; Matsumura, Akira*; Yamamoto, Tetsuya*; Shibata, Yasushi*; Yoshida, Fumiyo*; Akutsu, Hiroyoshi*; Yasuda, Susumu*; Matsushita, Akira*; Nakai, Kei*; Yamada, Takashi*; et al.
UTRCN-G-29, p.114 - 123, 2001/00
no abstracts in English
Matsushita, Akira*; Yamamoto, Tetsuya*; Matsumura, Akira*; Shibata, Yasushi*; Nose, Tadao*; Yamamoto, Kazuyoshi; Kumada, Hiroaki; Hori, Naohiko; Torii, Yoshiya
Proceedings of 9th International Symposium on Neutron Capture Therapy for Cancer, p.203 - 204, 2000/10
no abstracts in English
Matsumura, Akira*; Yamamoto, Tetsuya*; Shibata, Yasushi*; Akutsu, Hiroyoshi*; Yasuda, Susumu*; Matsushita, Akira*; Nakai, K.*; Yamada, Takashi*; Takano, Shingo*; Mizutani, Taro*; et al.
Proceedings of 9th International Symposium on Neutron Capture Therapy for Cancer, p.29 - 30, 2000/10
no abstracts in English
Yasuda, Susumu*; Yamamoto, Tetsuya*; Matsumura, Akira*; Shibata, Yasushi*; Akutsu, Hiroyoshi*; Matsushita, Akira*; Nakai, K.*; Nose, Tadao*; Yamamoto, Kazuyoshi; Kumada, Hiroaki; et al.
Proceedings of 9th International Symposium on Neutron Capture Therapy for Cancer, p.171 - 172, 2000/10
no abstracts in English
Saito, Yuji; Kimura, Hiroaki*; Suzuki, Yoshio*; Nakatani, Takeshi*; Matsushita, Tomohiro*; Muro, Takayuki*; Miyahara, Tsuneaki*; Fujisawa, M.*; Soda, Kazuo*; Ueda, Shigenori*; et al.
Review of Scientific Instruments, 71(9), p.3254 - 3259, 2000/09
Times Cited Count：187 Percentile：98.99(Instruments & Instrumentation)no abstracts in English
Kobayashi, Kiyoshi*; Yoshida, Akira*; Matsushita, Yoshitaka*; Nishimura, Chikashi*; Oyama, Yukiko*; Miyoshi, Shogo*; Izumi, Fujio*; Igawa, Naoki; Yamaguchi, Shu*
no journal, ,
Conduction properties of oxide ions and crystal structure refinement of La
(SiO
)
O
have been made by A.C.-impedance, electro-motive force of oxygen concentration cell, X-ray and neutron diffraction methods using the sample fabricated by the sol-gel method. The crystal structure of the sample can be refined by structural model with 
6
/
space group. Oxide ion conductivity is found to be predominant in wide oxygen partial pressure and temperature range based on the conductivity and electro-motive force measurements.
